Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia
Conditions: Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma Interventions: Drug: Pirtobrutinib; Drug: Obinutuzumab Sponsors: Inhye Ahn; Loxo Oncology, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Chronic Leukemia | Chronic Lymphocytic Leukemia | Leukemia | Lymphoma | Research